Pham, Phuong Anh http://orcid.org/0000-0002-3087-2825
Dressler, Corinna http://orcid.org/0000-0001-7075-2062
Eisert, Lisa http://orcid.org/0000-0002-1664-1094
Nast, Alexander http://orcid.org/0000-0003-3504-2203
Werner, Ricardo Niklas http://orcid.org/0000-0003-3209-1392
Funding for this research was provided by:
Lilly Deutschland (-)
Article History
Received: 24 September 2018
Accepted: 16 January 2019
First Online: 25 January 2019
Compliance with ethical standards
:
: Authors Phuong Anh Pham (PAP), Dr. Corinna Dressler (CD), Ricardo N. Werner, MD (RNW) declare that they have no conflicts of interest. Author Lisa Eisert, MD (LE) has received seminar participation fees from Pfizer (Enbrel), Leo Pharma (Daivobet, Protopic, Enstilar). Author Prof. Alexander Nast, MD (AN) has received institutional research grants/participated as an investigator (without personal honoraria) in research projects, advisory activities or trials from the following companies with an interest in psoriatic arthritis: Lilly, Novartis, Dermira. AN has received personal honoraria for lectures/educational activities from the following companies which—to his knowledge—currently have no interest in psoriatic arthritis: Bayer Healthcare, Pierre Fabre, Boehringer Ingelheim.
: This article does not contain any studies with human participants or animals performed by any of the authors.